Harrison W M, Cooper T B, Stewart J W, Quitkin F M, McGrath P J, Liebowitz M R, Rabkin J R, Markowitz J S, Klein D F
Arch Gen Psychiatry. 1984 Jul;41(7):681-5. doi: 10.1001/archpsyc.1984.01790180051006.
A previous study reported that unipolar depressives excrete significantly lower amounts of urinary tyramine-O-sulfate following oral administration of a tyramine hydrochloride load than do normal control subjects. This study replicates and extends those findings by showing that within the heterogeneous group of unipolar depressives, patients with melancholia and bipolar patients with a history of melancholia manifest a tyramine excretion deficit. A small subgroup of medication-free patients in remission from episodes of melancholia had abnormally low tyramine sulfate excretion levels while they were euthymic, supporting the suggestion that reduced tyramine sulfate excretion following oral tyramine loading is a trait marker for depression. Further study of the role of trace amines in affective illness is warranted. Clinical application is not warranted until further evaluation of the sensitivity, specificity, and reproducibility of this oral tyramine challenge test.
一项先前的研究报告称,单相抑郁症患者口服盐酸酪胺负荷后,尿中酪胺 - O - 硫酸盐的排泄量显著低于正常对照受试者。本研究通过表明在单相抑郁症的异质性群体中,忧郁症患者和有忧郁症病史的双相情感障碍患者表现出酪胺排泄缺陷,重复并扩展了这些发现。一小部分从忧郁症发作中缓解的未服药患者在心境正常时硫酸酪胺排泄水平异常低,支持了口服酪胺负荷后硫酸酪胺排泄减少是抑郁症特征性标志物的观点。有必要进一步研究痕量胺在情感障碍中的作用。在对这种口服酪胺激发试验的敏感性、特异性和可重复性进行进一步评估之前,不建议临床应用。